Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exclusive License Agreement to commercialise serplulimab – A Novel Anti-PD1 mAb in Europe & India
This collaboration strengthens the Intas novel biologics portfolio and deepens the existing strategic partnership between Henlius & Intas. Intas gains exclusive
Read More